Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNARF Regulatory News (NARF)

Share Price Information for NARF (NARF)

Share Price is delayed by 15 minutes
Get Live Data
0.475    -0.011 (-2.26%)
Bid:
0.45
Ask:
0.50
Spread: 0.05 (11.111%)
Market Cap: £8.06m
NARF Live PriceLast checked at - London Stock Exchange

Intraday NARF Share Chart

Holding(s) in Company

6 Mar 2023 07:00

RNS Number : 9266R
Narf Industries PLC
06 March 2023
 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE UK VERSION OF THE MARKET ABUSE REGULATION NO 596/2014 WHICH IS PART OF ENGLISH LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018, AS AMENDED. ON PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INFORMATION IS CONSIDERED TO BE IN THE PUBLIC DOMAIN.

 

6 March 2023

 

NARF INDUSTRIES PLC

 

 

Note, the list of major shareholders will be updated on the Company website at (https://narfgroup.com/investor-relations).

 

TR-1: Standard form for notification of major holdings

 

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii:

NARF INDUSTRIES PLC

1b. Please indicate if the issuer is a non-UK issuer  (please mark with an "X" if appropriate)

Non-UK issuer

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

x

An acquisition or disposal of financial instruments

An event changing the breakdown of voting rights

Other (please specify)iii:

3. Details of person subject to the notification obligationiv

Name

CIP Merchant Capital Limited

City and country of registered office (if applicable)

Guernsey

4. Full name of shareholder(s) (if different from 3.)v

Name

Merchant Capital GP Limited on behalf of Merchant Capital LP

City and country of registered office (if applicable)

Guernsey

5. Date on which the threshold was crossed or reachedvi:

28/02/2023

6. Date on which issuer notified (DD/MM/YYYY):

29/02/2023

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights of issuervii

Resulting situation on the date on which threshold was crossed or reached

3.28

3.28

55,625,000

Position of previous notification (if

applicable)

2.75

2.75

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii

A: Voting rights attached to shares

Class/type ofshares

ISIN code (if possible)

Number of voting rightsix

% of voting rights

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

GB00BMH18M70

55,625,000

3.28

SUBTOTAL 8. A

55,625,000

3.28

 

 

B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))

Type of financial instrument

Expirationdatex

Exercise/Conversion Periodxi

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights

N/A

SUBTOTAL 8. B 1

 

 

B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))

Type of financial instrument

Expirationdatex

Exercise/Conversion Period xi

Physical or cash

settlementxii

Number of voting rights

% of voting rights

N/A

 

SUBTOTAL 8.B.2

 

 

 

 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

 

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiii

x

Full chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv (please add additional rows as necessary)

Namexv

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

 

 

 

 

 

 

 

 

10. In case of proxy voting, please identify:

 

Name of the proxy holder

N/A

 

The number and % of voting rights held

N/A

 

The date until which the voting rights will be held

N/A

 

 

11. Additional information

 

 

 

 

 

 

ENDS

For further information on the Group please visit www.narfgroup.com or contact:

Rory Heier

NARF

Tel: +44 (0) 20 3468 2212

Catherine Leftley/Charlotte Page/Isabel de Salis

St Brides Partners

narf@stbridespartners.co.uk

Peter Krens

Tennyson Securities

Tel: +44 (0)207 186 9030

 

 

About NARF Industries plc

Narf Industries (LSE: NARF)(OTCQB: NFIN.F) is a US based cyber security group specialising in high-end threat intelligence with a focus on critical infrastructure. The Group leads commissioned cyber security R&D and is commercialising a portfolio of products including TIGR that can be used by utilities and cyber first responders to restore power to electric grids and protecting other key infrastructure that have suffered a cyber-attack. The Group aims to further strengthen its portfolio both organically and via acquisition; its team of highly qualified cyber security experts is well placed to identify such opportunities.

 

 

Important notice

The content of this announcement has not been approved by an authorised person within the meaning of the Financial Services and Markets Act 2000 (FSMA). This announcement has been issued by and is the sole responsibility of the Company. The information in this announcement is subject to change. This announcement is not an offer of securities for sale into the United States. The securities referred to herein have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the Securities Act), and may not be offered or sold, directly or indirectly, in or into the United States, except pursuant to an applicable exemption from registration. No public offering of securities is being made in the United States. This announcement is not for release, publication or distribution, directly or indirectly, in or into the United States, Australia, Canada, the Republic of South Africa, Japan or any jurisdiction where to do so might constitute a violation of local securities laws or regulations (a Prohibited Jurisdiction). This announcement and the information contained herein are not for release, publication or distribution, directly or indirectly, to persons in a Prohibited Jurisdiction unless permitted pursuant to an exemption under the relevant local law or regulation in any such jurisdiction.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLJAMMTMTJMTLJ
12
Date   Source Headline
16th Apr 20267:00 amRNSTrading Update and New Contract Win
26th Mar 20267:00 amRNSInvestor Presentation
4th Dec 20257:00 amRNS$3.6m Contract Awarded by U.S. Government Agency
17th Nov 20257:00 amRNSInterim Results & Notice of Investor Presentation
2nd Oct 20252:37 pmRNSResult of AGM
4th Sep 20257:00 amRNSNotice of AGM
3rd Sep 20257:00 amRNSRanger.ai Secures DoD Marketplace Approval
31st Jul 20257:00 amRNSAudited Financial Results
24th Jul 20257:00 amRNSInvestor Presentation
27th Jun 20257:00 amRNSRanger open-source risk detection platform launch
20th Jun 20257:00 amRNSDirector's Loan Extension
4th Apr 20257:00 amRNSProgress update re: commercialization
6th Mar 20257:00 amRNSUS$6.8M Multi-Phase Contract with US Gov Agency
30th Dec 20247:00 amRNSInterim Results
7th Nov 20247:00 amRNSBusiness Update & Financial Guidance
4th Oct 202412:30 pmRNSResult of AGM
5th Sep 202412:00 pmRNSNotice of AGM
27th Aug 20247:00 amRNS$1.3m USAF Contract For AI-Powered Social Cyber
31st Jul 20247:00 amRNSFinal Results
12th Jun 20248:47 amRNSHolding(s) in Company
6th Jun 20247:00 amRNSOperational Update
1st May 20247:00 amRNSBreakthrough Threat Intel Capability Accelerated
8th Apr 20247:00 amRNSc.$500k contract win for US DOE Program
25th Mar 20247:00 amRNSNew Corporate Website
19th Mar 20247:01 amRNSHolding(s) in Company
19th Mar 20247:00 amRNSHolding(s) in Company
13th Mar 20247:00 amRNSHolding(s) in Company
12th Mar 20247:00 amRNSAwarded $1.3 Million Contract
1st Mar 202412:00 pmRNSInvestor Meet Company Presentation
22nd Feb 20242:58 pmRNSHolding(s) in Company
22nd Feb 20241:01 pmRNSResult of AGM
22nd Feb 20247:00 amRNSNew Task Order Awards of $1.6 million
19th Feb 20247:00 amRNSAppointment of Joint Broker
29th Jan 20245:23 pmRNSNotice of AGM
25th Jan 20247:00 amRNSCorporate Update
18th Dec 20237:00 amRNSCritical Infrastructure Collaboration
26th Oct 20237:00 amRNSKey New Executive Hire to Drive Growth in GS&S
9th Oct 20237:00 amRNS$1.8m US Healthcare Cyber Security Contract
5th Oct 20231:45 pmRNSHolding(s) in Company
27th Sep 20237:00 amRNSInterim Results
11th Sep 20237:00 amRNSEMPLOYEE SHARE OPTION PLAN
4th Sep 20237:00 amRNSNew Task Order Awards of $1.2 million
14th Jul 20232:26 pmRNSLIFTING OF SUSPENSION
11th Jul 20232:46 pmRNSFinal Results
30th Jun 20237:00 amRNSTemporary Suspension Update
2nd May 20237:30 amRNSSuspension - Narf Industries Plc
26th Apr 20237:30 amRNSAppointment of Interim CFO
26th Apr 20237:00 amRNSAudit Update
24th Apr 20237:00 amRNSDirectorate Change
19th Apr 20231:14 pmRNSHolding(s) in Company
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.